NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001547

Registered date:03/12/2008

Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancer

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedcolorectal cancer
Date of first enrollment2008/09/01
Target sample size400
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeResponse rate, Time to Treatment failure, Adverse events rate, Progression free survival, Overall survival
Secondary Outcome

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1)Prior bevacizumab administration 2)FOLFIRI+bevacizumab in patients with previous CPT-11-based chemotherapy, or FOLFOX+bevacizumab in patients with previous L-OHP-based chemotherapy

Related Information

Contact

public contact
Name Toshikazu Moriwaki
Address Japan
Telephone
E-mail
Affiliation University of Tsukuba Gastroenterology
scientific contact
Name Ichinosuke Hyodo
Address 1-1-1 Tennodai, Tsukuba-shi, Ibaraki-ken, Japan Japan
Telephone
E-mail
Affiliation University of Tsukuba Gastroenterology